📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. (2017)

First Author: Alharbi NK

Attributed to: Tropical Infectious Disease Consortium: Sustaining, Expanding and Accelerating Product Development funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2017.05.032

PubMed Identifier: 28579232

Publication URI: http://europepmc.org/abstract/MED/28579232

Type: Journal Article/Review

Volume: 35

Parent Publication: Vaccine

Issue: 30

ISSN: 0264-410X